Phage therapy: A modern tool to control bacterial infections

Pakistan Journal of Pharmaceutical Sciences

Volumn 28, Issue 1, 2015, Pages 265-270

  Qadir, Muhammad Imran ^a  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Antibiotic resistance; Bacteriophage therapy; Infectious diseases

Indexed keywords

ANTIBIOTIC AGENT; CAPSID PROTEIN; LYSOSOME ENZYME; NEUTRALIZING ANTIBODY;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIOPHAGE THERAPY; BURN; CIRCULATION; DIABETES MELLITUS; DIABETIC WOUND; DIARRHEA; DRUG ADMINISTRATION ROUTE; DRUG SAFETY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HELICOBACTER INFECTION; HISTORY OF MEDICINE; HOST CELL; HUMAN; INFECTION; INFECTION CONTROL; LYSIS; MASTOIDITIS; NONHUMAN; PLASMA CLEARANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SKIN GRAFT; STAPHYLOCOCCUS INFECTION; TRANSGENIC ORGANISM; UPPER RESPIRATORY TRACT INFECTION; VIROLOGY; WOUND; ANIMAL; BACTERIA; BACTERIAL INFECTIONS; GENE THERAPY; GENETICS; GENOTYPE; HISTORY; MICROBIOLOGY; PATHOGENICITY; PROCEDURES;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOPHAGES; DRUG RESISTANCE, BACTERIAL; GENETIC THERAPY; GENOTYPE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 84920559317     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Ahmad M, Mahmood Q, Gulzar K, Akhtar MS, Saleem M and Qadir MI (2012). Anti-hyperlipidaemic and hepatoprotective activity of Dodonaea viscosa leaves extracts in alloxan-induced diabetic rabbits (Oryctolagus cuniculus). Pak. Vet. J., 32(1): 50-54.
2. Ali M, Qadir MI, Saleem M, Janbaz KH, Gul H, Hussain L and Ahmad B (2013). Hepatoprotective potential of Convolvulus arvensis against paracetamol-induced hepatotoxicity. Bangladesh J. Pharmacol., 8: 300-304.
3. Amin N, Qadir MI, Khan TJ, Abbas G, Ahmad B, Janbaz KH and Ali M (2012). Antibacterial activity of Vacuum liquid chromatography (VLC) isolated fractions of chloroform extracts of seeds of Achyranthes aspera. J. Chem. Soc. Pak., 34(3): 589-592.
4. Asif MA and Qadir MI (2011). Molecular approaches for development of malarial vaccines. Rev. Pharmacol., 4: 276-278.
5. Caldwell J (1996). The importance of drug metabolism studies for efficient drug discovery and development. DMPK., 11: 119-126.
6. Capparelli R, Ventimiglia I, Roperto S, Fenizia D and Iannelli D (2006). Selection of an Escherichia coli O157: H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect, 12: 248-253.
7. Carlton RM (1999). Phage therapy past history and future prospects. Arch. Immunol. Ther. Exp., 5: 267-274.
8. Catherine SM, Merisela V and Joe AF (2007). Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model. Antimicrob. Agents Chemother., 51: 1934-1938.
9. Chen SY, Wang JT, Chen TH, Lai MS, Chie WC, Chien KL, Hsueh PR, Wang JL and Chang SC (2010). Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia. Medicine (Baltimore), 89: 285-294
10. Chernomordik AB (1989). Bacteriophages and their therapeutic-prophylactic use. Med. Sestra., 6: 44-47.
11. d'Hrelle F (1917). Sur un microbe invisible antagoniste des bac. dysentériques. Crit. Rev. Acad. Sci. Paris, 165: 373.
12. Eaton D and Jones SB (1934). Bacteriophage therapy Review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA., 23: 1769-1939.
13. Ehsan O, Qadir MI, Malik SA, Abbassi WS and Ahmad B (2012). Efficacy of nanogold-insulin as a hypoglycemic agent. J. Chem. Soc. Pak., 34(2): 365-370.
14. Hussain A, Khalid SH, Qadir MI, Massud A, Ali M, Khan IU, Saleem M, Iqbal MS, Asghar S and Gul H (2011). Water Uptake and Drug Release Behaviour of Methyl Methacrylate-co-itaconic acid [P(MMA/IA)] Hydrogels Cross-linked with Methylene Bisacrylamide. J. Drug Delvr. Sci. Tech., 21(3): 249-255.
15. Janbaz KH, Jan A, Qadir MI and Gilani AH (2013a). Spasmolytic, bronchodilator and vasorelaxant activity of methanolic extract of Tephrosia purpurea. Acta. Pol. Pharm., 79(2): 261-269.
16. Janbaz KH, Nizsar U, Ashraf M and Qadir MI (2012). Spasmolytic, bronchodilator and antioxidant activities of Erythrina superosa Roxb. Acta. Pol. Pharm., 69(6): 1111-1117.
17. Janbaz KH, Qadir MI, Jan A and Gilani AH (2013b). Anti-diarrheal activity of methanolic extract of Tephrosia purpurea. Acta. Pol. Pharm., 79(2): 345-347.
18. Javed F, Qadir MI, Janbaz KH and Ali M (2011). Novel drugs from marine microorganisms. Critical Rev. Micro., 37(3): 245-249.
19. Jumpei U, Yoshihiro M, Iyo T, Russ CW, Hiroshi W and Shigenobu M (2009). Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice. Microbiol. immunol., 53: 301-304.
20. Kaczkowski H, Weber-Dabrowska B, Dabrowski M, Zdrojewicz Z and Cwioro F (1990). Use of bacteriophages in the treatment of chronic bacterial diseases. Wiad Lek., 43: 136-141.
21. Khalid SH, Qadir MI, Massud A, Ali M and Rasool MH (2009). Effect of degree of cross-linking on swelling and drug release behaviour of poly (methyl methacrylate-co-itaconic acid) [P(MMA/IA)] hydrogels for site specific drug delivery. J. Drug Delvr. Sci. Tech., 19(6): 413-418.
22. Kochetkova VA, Mamontov AS, Moskovtseva RL, Erastova EI, Trofimov EI, Popov MI and Dzhubalieva SK (1989). Phagotherapy of postoperative suppurativeinflammatory complications in patients with neoplasms. Sov. Med., 6: 23-26.
23. Leverentz B, Conway WS, Alavidze Z, Janisiewicz WJ, Fuchs Y, Camp MJ, Chighladze E and Sulakvelidze A (2001). Examination of bacteriophage as a biocontrol method for salmonella on fresh-cut fruit: A model study. J. Food Prot., 64:1116-1121.
24. Levin B and Bull JJ (1996). Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Naturalist, 147: 881-898.
25. Lu TK and Collins JJ (2009). Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. PNAS., 106: 4629-4634.
26. Mallhi TH, Qadir MI, Khan YH, Ali M (2014). Hepatoprotective activity of aqueous methanolic extract of Morus nigra against paracetamol-induced hepatotoxicity in mice. Bangladesh J. Pharmacol., 9: 60-66.
27. Masood MI, Qadir MI, Shirazi JH and Khan IU (2011). Beneficial effects of lactic acid bacteria on human beings. Critical Rev. Micro., 37(1): 91-98.
28. Meladze GD, Mebuke MG, Chkhetia NS, Kiknadze NI, Koguashvili GG, Timoshuk II, Larionova NG and Vasadze GK (1982). The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura. Grudn Khir., 1: 53-56.
29. Merril CR, Scholl D and Adhya S (2006). Phage therapy. In: Calendar R., ed. The Bacteriophages, 2nd edn. New York, NY: Oxford University Press, pp. 725-741.
30. Naz S, Qadir MI, Ali M and Janbaz KH (2012). Nanotechnology for imaging and drug delivery in cancer. J. Chem. Soc. Pak., 34(1): 107-111.
31. Qadir MI (2009). Medicinal and cosmetological importance of Aloe vera. Int. J. Nat. Ther., 2: 21-26.
32. Qadir MI (2010). Medicinal values of ginger. Int. J. Nat. Ther., 3: 19-22.
33. Qadir MI (2011). Qadirvirtide. Pak. J. Pharm. Sci., 24(4): 593-595.
34. Qadir MI and Malik SA (2009). Effect of Eugenia jambolana leaves extracts on blood glucose levels of experimental diabetic rabbits. Pharmacologyonline, 3: 829-835.
35. Qadir MI and Malik SA (2010). Anti-diabetic activity of inorganic metals Eugenia jambolana Lam. (Myrtaceae) flowers. Pharmacologyonline, 2: 979-985.
36. Qadir MI and Malik SA (2011). Genetic variation in the HR region of the env Gene of HIV: A perspective for resistance to HIV fusion inhibitors. AIDS Res. Hum. Retrovir., 27(1): 57-63.
37. Qadir MI, Ali M, Ali M, Saleem M, Hanif M (2014a). Hepatoprotective activity of aqueous methanolic extract of Viola odorata against paracetamol-induced liver injury in mice. Bangladesh J. Pharmacol., 9: 198-202.
38. Qadir MI, Murad MSA, Ali M, Saleem M, Farooqi AA (2014b). Hepatoprotective effect of leaves of aqueous ethanol extract of Cestrum nocturnum against paracetamol-induced hepatotoxicity. Bangladesh J. Pharmacol., 9: 167-170.
39. Ryan EM, Gorman SP, Donnelly RF and Gilmore BF (2011). Recent advances in bacteriophage therapy: How delivery routes, formulation, concentration and timing influence the success of phage therapy. J. Pharm. Pharmacol., 63: 1253-1264.
40. Sahoo C, Tamhankar AJ, Johansson E and Stalsby LC (2010). Antibiotic use, resistance development and environmental factors. BMC Public health, 10: 629.
41. Saleem M, Ahmed B, Qadir MI, Mahrukh, Rafiq M, Ahmad M, Ahmad B (2014a). Hepatoprotective effect of Chenopodium murale in mice. Bangladesh J. Pharmacol., 9: 124-128.
42. Saleem M, Karim M, Qadir MI, Ahmad B, Rafiq M, Ahmad B (2014b). In vitro antibacterial activity and phytochemical analysis of hexane extract of Vicia sativa. Bangladesh J. Pharmacol., 9: 189-193.
43. Samsygina GA and Boni EG (1984). Bacteriophages and phage therapy in pediatric practice. Pediatria, 4: 67-70.
44. Stroj L, Dabrowska BW, Partyka K, Mulczyk M and Wojcik M (2000). Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol. Neurochir. Pol., 3: 693-698.
45. Sulakvelidze A, Alavidze Z and Morris JG (2001). Bacteriophage therapy. Antimicrob. Agents Chemother., 45: 649-659.
46. Summers WC (1999). Felix d'Herelle and the origins of molecular biology. Yale University Press, New Haven.
47. Vitiello CL, Merril CR and Adhya S (2005). An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res., 114: 101-103.